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Introdução: A cicatrização de tecidos é um processo dinâmico, caracterizado 
por uma sequência de fases que se manifestam através de sinais e sintomas 
inflamatórios entre os quais o rubor, o edema, a dor e a perda de função1. 
O quitosano é um polímero natural derivado da desacetilação da quitina com 
a capacidade de facilitar o processo regeneração e cicatrização de tecidos2. 
Possui, também, outras propriedades fundamentais tais como a 
biocompatibilidade, biodegrabilidade, capacidade hemostática e 
antimicrobiana3. O quitosano é solúvel em meio ácido e possui uma boa 
afinidade com os tecidos, podendo ser usado na forma de gel4,5. 
Objetivos: O objetivo deste estudo experimental foi avaliar a influência do 
quitosano no processo de cicatrização da mucosa oral.  
Materiais e Métodos: Este estudo experimental é do tipo split-mouth design. 
A população em estudo é constituída por 8 pacientes que foram submetidos a 
duas cirurgias, uma utilizando o quitosano e outra de controlo. A informação 
foi registada fotograficamente e recorrendo a uma ficha de controlo pós-
operatório. 
Resultados: Neste estudo, foram verificadas diferenças no processo de 
cicatrização da mucosa oral entre os casos de controlo e os casos em que foi 
utilizado o quitosano. Numa fase inicial, verificaram-se sinais e sintomas 
inflamatórios em ambos os casos, sendo que, naqueles em que foi 
administrado o quitosano, estes observaram-se num menor período de 
tempo. Nestes mesmos casos, também se observou uma diminuição da dor e 
ausência de hemorragia.  
Conclusões: De acordo com a bibliografia e os resultados observados, o 
quitosano acelera a cicatrização através da atração e ativação dos neutrófilos 
e macrófagos e da estimulação da agiogénese6. Também devido às suas 
propriedades antimicrobiana e hemostática, conclui-se que o quitosano pode 
melhorar a qualidade pós-operatória dos pacientes, permitindo uma rápida 
cicatrização com menos complicações. 
 










Introduction: The healing process is a dynamic procedure, characterized by 
a sequence of phases and accompanied by some classical symptoms of 
inflammation such as redness, swelling, pain and loss of function1. 
Chitosan, a naturally derived polymer from the deacetylation of chitin, has 
appropriate proprieties for the use in several biomedical fields that contributes 
to the tissue healing and regeneration2. Proprieties such as biocompatibility, 
biodegradability, hemostatic, antimicrobial activity and the capacity to 
influence wound healing indicate that it could be applied in periodontal 
therapy such as the wound healing of the oral mucosa3. Chitosan is soluble in 
an acidic environment and exhibits excellent tissue affinity and consequently it 
could be used in hydrogel forms4,5.  
Aim: The aim of this experimental study is to assess possibilities of the 
chitosan to influence the healing process of the oral mucosa.  
Materials and Methods: This experimental pilot study is a split-mouth design 
of 8 patients where the studied group was subjected to two oral surgeries, one 
with chitosan hydrogel into the socket and other without biomaterial. The data 
was collected by means of a questionnaire and photography. 
Results: There were differences in the healing process of the oral mucosa in 
sites where chitosan was used compared to the control. Some classic signs of 
inflammation were observed in a short period of time where chitosan acts. In 
these cases it was observed a decrease in pain and absence of bleeding. 
Conclusions: According to the references and the obtained results chitosan 
favoured the healing process by attraction and activation of neutrophils and 
macrophages and stimulation of angiogenesis6. Other proprieties such as 
hemostatic and antimicrobial activity also play an important role in wound 
healing. All these peculiar abilities make the chitosan essential in a 
postoperative quality of patients, allowing a rapid healing of the wound, with 
less complications. 
 


































 Wound Healing 1.1.
A wound is a type of injury defined as damage or disruption to the 
normal anatomical structure and function which may extend from a simple 
break in the epithelial integrity of skin or oral mucosa or extending into tissue 
with damage to other structures such as muscles, nerves, parenchymal 
organs and even bone which can be caused by a drilling, trauma or even a 
cut due to a surgical incision7. 
Whatever the cause of the wound damage is, it will always disrupt the 
environment with it and a physiological response will start  in a dynamic and 
complex process involving several events, including bleeding, coagulation, 
initiation of an acute inflammatory response, regeneration, migration and 
proliferation of connective tissue and parenchyma cells7.   
 
1.1.1. Phases of the Healing Process 
Wound healing is a dynamic process initiated at the time of physical 
injury and it proceeds continuously throughout the repair process that is 
characterized by a sequence of orchestrated phases: hemostasis, 
inflammation, cellular migration and proliferation, protein synthesis, wound 
contraction and remodelling6,8,9. Besides, only inflammatory, proliferative and 
remodelling phase are mainly present due to the overlap of phases8.  
 
1.1.2. Coagulation and Hemostais Phase 
The coagulation and hemostasis begins immediately after injury with 
the objective to prevent exsanguination and consequently protect the vascular 
system, keeping it intact, so that the function of the vital organs can remain 
unharmed. In a long term it supplies a matrix for invading cells that are 
needed in the other phases of healing7.  
When there is an injury to a tissue a neuronal reflex mechanism occurs 
that leads to a rapid constriction of vessels due to contraction of a vascular 




process the amount of fibrin is deposited at the wound site and through a 
dynamic balance between endothelial cells, thrombocytes, coagulation and 
fibrinolysis regulates hemostasis7. 
Together with hemostatic events a clot formation and a platelet 
aggregation occur in order to limit blood loss7. 
When blood spills into the site of injury contact with exposed collagen 
and other extracellular matrix components it results in a release of clotting 
factors from the platelets and the formation of a blood clot, composed by 
fibronectin, fibrin, vitronectin and thrombospondin. These events happen by 
an extrinsic and intrinsic pathways7 
Besides hemostasis, the coagulum is also important for other next 
phases to provide a provisional matrix for cell migration. The cytoplasm of 
platelets contains α-granules with growth factors and cytokines (such as 
platelet derived growth factor [PDGF]), transforming growth factor-β (TGF-β), 
epidermal growth factor and others which promote a cascade of wound 
healing through activation and attraction of neutrophils and, later, 
macrophages, endothelial cells and fibroblasts8.  
The first phase involves infiltration of neutrophils and monocytes into 
the clot which clean the wounded area of necrotic tissue and bacteria and 
then monocytes release fibroblast in growth factor-2 and vascular endothelial 
initiating the formation of granulation tissue7.  
 
1.1.3. Inflammatory Phase 
The inflammation stage begins immediately after injury and the main 
aim is the removal of debris, damage tissue, and bacteria by neutrophils and 
macrophages10.  
The first phase involves vasoconstriction, platelet aggregation at the 
injury site and then infiltration of leukocytes and the T lymphocytes to the 
wound area. This stage is commonly accompanied by some classical 
symptoms such as pain, redness and oedema1. In a more specific analysis T 
velnar et al divide this stage into two separate phases, an early inflammatory 





1.1.1.1. Early Inflammatory Phase 
This stage starts during the late phase of coagulation with the aim of 
activating the complement cascade and initiating molecular events. In order to 
prevent the infection of the wound various chemoattractive agents including 
TGF-β, complement components such as C3a and C5a, and formylmethionyl 
peptides produced by bacteria and platelet products attract by neutrophils 
(within 24-36 of injury) to the wound site to destroy and remove bacteria, 
foreign particles and damaged tissue, through phagocytosis7,8.  
Intercellular adhesion molecule-1 (ICAM-1), an immunoglobulin cell 
expressed by several cell types including leukocytes and endothelial cells 
plays an important role in recruiting and retaining neutrophils, and it is 
involved in neutrophil migration into the gingival sulcus in periodontal tissue 
making it a key regulator of wound healing in the periodontium11. 
After all the contaminating bacteria has been removed, neutrophil 
activity gradually changes and they should be removed before the 
progression to the next phase of healing8. 
 
1.1.1.2. Late Inflammatory Phase 
This phase corresponds approximately to 48-72h of the inflammatory 
phase which macrophages appear and continue the process of phagocytosis. 
They are attracted to the wound by chemoattractive agents as clotting factors, 
complement components, cytokines (PDGF, TGF-β, leukotriene B4 and 
platelet factor IV), elastin and collagen breakdown products7. 
Macrophages have a longer lifespan than neutrophils and they have an 
important role in late stages of the inflammatory response activating 
keratinocytes, fibroblasts and endothelial cells and providing an abundant 
reservoir of potent tissue growth factors (TGF-β, TGF-α, heparin binding 
epidermal growth factor, fibroblast growth factor [FGF], collagenase)7. 
Lymphocytes, last cells to enter in the wound site in the inflammatory 
phase, are attracted 72h after injury by the action of interleukin-1 (which has 
an important role in collagenase regulation), complement components and 





1.1.4.  Proliferative Phase 
After several hours of injury, proliferative phase begins with the 
migration and proliferation of epithelial cells. This phase proceeds over the 
next 5-14 days and involves a new tissue formation, fibroblast migration and 
deposition of newly synthesized extracellular matrix (that replace the 
provisional network composed of fibrin and fibronectin), granulation and re-
epithelialization and restores vascular network3,6,7. 
 
1.1.1.1. Fibroblast Migration 
In the first three days after injury, fibroblasts and myofibroblast are 
stimulated and attracted into the wound by factors like TGF-β and PDGF 
(released by inflammatory cells and platelets). On the third day after injury 
fibroblasts appear in the wound, produce the matrix proteins hyaluronan, 
fibronectin, proteoglycans and type 1 and type 3 procollagen, which allow in 
the end of the first week an abundant accumulation of extracellular matrix to 
supports cell migration. After this, fibroblasts change their phenotype and 
differentiate in myofibroblasts (which contain thick actin bundles below the 
plasma membrane and actively extend pseudopodia, attaching to fibronectin 
and collagen in the extracellular matrix). This cells helps wound repair by 
contracting the edges of the wound using their smooth muscle type actin-
myosin complex. After this, fibroblasts are eliminated by apoptosis7. 
 
1.1.1.2. Collagen synthesis 
Collagen is synthesized by fibroblasts and it is an important element of 
tissues for their integrity and strength because it acts as a structural scaffold 
in tissues. It influences cell behaviour and their functions including cell shape 
differentiation, migration, synthesis of a number of proteins and the regulation 
of the quantity and quality of matrix deposition7,12. 
 
1.1.1.3 Angiogenisis and granulation tissue formation 
In an initial situation there is no vascular supply in wound centre. The 




uninjured vessels which allows the angiogenic capillary sprouts to invade the 
fibrin / fibronectin-rich wound clot and within a few days to compose and 
organize a microvascular network through the granulation tissue7. 
The attraction of neutrophils and macrophages in the hemostatic phase 
increases the segregation of angiogenic factors  such as FGF, vascular 
endothelial growth factor (VEGF), PDGF, angiogenin, TGF-α and TGF-β that 
promote angiogenesis and have an important role as modulator of cell growth 
and differentiation7. 
The actin network acts as a mechano-effector in the dynamic 
reorganization and in coordinator of cell migration. Cellular mobility requires 
three distinct actions: protrusion of the leading edge of the cell, adhesion of 
the leading edge and de-adhesion of the cell body and rear, and cytoskeletal 
contraction to pull the cell forward7,12. 
Contractile forces are transmitted through the integrin-cytoskeletal 
connections and they allow the cell to pull cytoplasm forward by generating 
traction to the substratum and these forces can be high enough to deform the 
extracellular matrix and rearrange it significantly7. 
The granulation tissue is composed by macrophages, proliferating 
fibroblasts, vascularized stroma, collagen matrix, fibrinogen, fibronectin and 
hyaluronic acid that replaces the fibrin based provisional matrix and with 
collagen accumulation it gradually matures to produce a scar7. 
In periodontology, this is an important phase because the population of 
gingival fibroblasts is stimulated to proliferate and several growth factors may 
promote cell division to reconstruction of injured gingival and periodontal 
tissues3.  
 
1.1.5. Remodelling phase 
At last remodelling phase is characterized by a reorganization and 
contraction of newly formed matrix8. This phase is responsible for the 
formation and the development of new epithelium which involves remodelling 
of collagen from type III to I, the cellular activity reduces and the number of 




An acute wound is regulated by mechanisms that maintain a delicate 
balance between degradation and synthesis to accomplish normal healing. 
While there is a maturation of intracellular matrix, collagen bundles increase in 
diameter and hyaluronic acid and fibronectin are degraded. Neutrophils, 
macrophages and fibroblasts produce matrix metalloproteinase enzymes that 
are responsible for the degradation of collagen7.  
Initially the deposition of collagen bundles is disorganized however, in 
the final stages of the remodelling phase, the new collagen matrix becomes 
more oriented and cross linked due to the wound contraction which the 
underlying connective tissue shrinks in size and brings the wound margins 
closer together (owing to fibroblast interactions with the extracellular matrix)7. 
With time, metabolic activity at the wound site decreases along with the 
growth arrest of capillaries and decline of blood and the final results are a fully 
matured scar with decreased number of cells and blood vessels and a high 
tensile strength7. 
The acquired final strength of the tissue depends on the localization of 
the repair and its duration, but the strength achieve can never be the same 
compared to unwounded tissue, because collagen fibres may regain 




 Classification of wounds 1.2.
In the literature we can find different classifications for the wounds. The 
healing time is an important parameter to consider in that we can classify 
wounds accordingly to three types: acute wounds, chronic wounds or 
complicated wounds. In the first case, which will be more frequent in our 
experimental work, wounds repair themselves and that proceed normally by 
following a timely and orderly healing pathway with the anatomical and 
functional restauration which the time course of healing usually ranges from 5 
to days, or within 30 days. This type of wound may be the result of traumatic 
loss of tissue or a surgical procedure such as an operation for removing 
tumour or a tooth extraction7.  
Chronic wounds are characterized by failure in the normal healing 
process in which the wound is not repaired in an orderly and timely manner 
and the stages of healing process will be prolonged and repeated several 
times. Several factors such as infection, tissue hypoxia, necrosis, excess 
levels of inflammatory cytokines will result in a continuous state of 
inflammation that creates a sequence of tissue responses that together 
perpetuate a non-healing state7.  
Complicated wounds are defined as a combination of an infection and 
a tissue defect which poses a constant threat to the wound. Such wounds 
may result due to the traumatic or post-infectious aetiology, or a wide tissue 
resection7. 
Other criteria taken into account in wound classification include the 
degree of contamination (Aseptic wounds, contaminated wounds and septic 
wounds), aetiology (according to the trigger factor into contusions – 
abrasions, avulsions, lacerations, stab wounds, shot wounds and burns) and 
morphological characteristics13. 
Other classifications are established for wound healing accordingly to 
the type of closure: primary intention (when it’s possible an approximation of 
wound margins or by placement and all layers are close), second intention 
(describe deep layers closed but superficial layers are left to heal from the 
inside out) or third intention (also referred to as delayed primary closure). An 




the operative room where the wound is usually healed at a minimum of time 
with minimal oedema, no local infection, without separation of the wound 
edges and with minimal scar formation13.  
1.2.1. Closure Technique 
Primary closure technique is the complete closure of extraction socket 
by way of repositioning of the flaps by sutures aimed at wound healing by 
primary intention which avoid the contamination from the oral cavity . This 
technique prevents drainage of the socket, preserving vital coagulum that acts 
as a space-occupying agent14. 
Secondary closure technique involves healing of the socket by 
secondary intention. Egbor P. et al observed a significant reduction in post-
operative swelling and trismus in subjects that had dressing of the sockets 
compared with those with primary closure but the effects on pain reduction 
were not statically significant14. 
One of the inclusion criteria for our study is the healing by primary 





 Chitin and Chitosan 1.3.
Nowadays, multiple biomaterials are being investigated for wound healing 
whose function is to preserve hydration of the wound in order to optimize 
regeneration, protect against infection, guarantee uniform cell distribution, 
maintain cell viability and phenotype, and induce migration and proliferation of 
epithelial cells, fibroblasts and endothelial cells, while fulfilling prerequisites 
concerning structure and biocompatibility to promote wound healing8,9. This 
has increased the interest in chitosan to produce specialized biomaterials in 
wound healing.  
 
1.3.1. Chitin 
Chitin, a natural polysaccharide of major importance, is synthesized by an 
enormous number of living organisms and it is considered the most abundant 
polymer after cellulose. Chitin is a structural component in the exoskeleton of 
arthropods or in the cell walls of fungi and yeast and it is extracted from 
crustaceans like crab and shrimp shells by acid treatment. This treatment 
allows to dissolve calcium carbonate and then, by alkaline extraction, to 
solubilize proteins.  By partial deacetylation of chitin, under alkaline 
conditions, we can obtain chitosan4,15,16. 
 
1.3.2. Chitosan 
Chitosan, a linear biopolymer extracted from N-acetylated of chitin, is a 
cationic polysaccharide containing copolymers of glucosamine and its 
molecular structure comprises a linear backbone linked through glycosidic 
bonds with random copolymer of β-(1–4)-linked D-glucosamine and N-acetyl-
D-lucosamine5,15,17,18.  
Glucosamine is the major component of chitosan and it’s a natural substance 
produced in the body from glucose and it is involved in manufacture of 
glycosaminoglycan which forms cartilage tissue in the body and it is also 
present in tendons and ligaments19. 
Chitosan is a weak base insoluble in water but becomes soluble in aqueous 




slightly crystalline character but an acidic environment enables the free amino 
groups of chitosan to become protonated. The high positive charge of 
chitosan permits the formation of a polyelectrolyte complex hydrogel with 
polyanionic species in an acidic environment4. 
Tissue engineering has shown interest in chitosan to culture hepatocytes, 
fibroblasts and cartilage cells due to its scalloped structure and the ability to 
promote cell attachment and growth10.  
Chitosan has shown a minimal body reaction and may be applied in 
periodontal therapy for tissue-reconstruction purposes due to their ability to 
promote cell proliferation of human gingival fibroblasts and stimulate wound 
healing.  It actives macrophages and mononuclear cell and induces the 
production of various growth factors that enhance wound healing and bone 
formation 4,21. Chitosan membranes have been used to promote skin, tendon, 
bone and periodontal wound healing which allows a significant histological 
evidence of tissue regeneration reported but the precise role of chitosan in 
modulating cell-regenerative responses in periodontal cells remains to be 
studied3. 
No data on the carcinogenic potential of chitosan was found in literature and 
the N-acetylglucosamine, a constituent of chitosan, also showed no evidence 
of carcinogenicity when dosed at low levels in the diet of rats during 2 years22. 
A very small portion of the human population exhibits allergies to marine 
crustaceans but chitosan and chitin-derived products are shown to be safe 
and well tolerated in patients with crustacean allergy23. This allergy is caused 
by IgE antibodies to antigens in the flesh of the shellfish and not to the shell, 
so the use of chitosan is safe for patients with crustaceans allergy24. 
Chitosan has attracted great attention in dentistry because of its biological 
properties such as biocompatibility, biodegradability, bioadhesion, 
antimicrobial, antibacterial, hemostatic and non-toxic effect25.  
1.3.3. Properties 
Biocompatible 
In this area it’s important to understand the definition of biocompatibility which 
according to The European Society for Biomaterial corresponds to the 




therapy, without eliciting any undesirable local or systemic effects in the 
recipient or beneficiary of that therapy, but generating the most appropriate 
beneficial cellular or tissue response in that specific situation, and optimizing 
the clinically relevant performance of that therapy. This propriety allows the 
study of the chitosan like a material in interact with the surrounding 
environment, instead of being ignored by them26. 
The positive charges of chitosan usually provides a great interaction with cell 
membranes (which are negatively charged) due to ionic interchanges 
between the intercellular and extracellular medium. This means that highly 
deacetylated chitosan which has more number of positively charged amino 
groups has a naturally higher propensity for cell interaction26. 
The effects of chitosan have been the subject of several toxicological studies 
in a medical field and in general it showed its biocompatibility18. For example, 
in vitro studies showed that chitosan with a degree of deacetylation ranging 
from 53-97,5%DD have been biocompatible with human neonatal primary 
keratinocytes with fibroblasts grown (fully deacetylate chitosan does not serve 
as a substrate for enzymatic degradation by lysozyme)18,24. Similar results 
were seen with primary human fibroblasts, each cell line adhered to either 
side of the chitosan membranes, proliferating and remaining viable for up to 
14 days18.  
Human volunteers have been orally taken levels of 6.75g of chitosan daily 
with 
no adverse effects reported and chitosan were reported as safe27,28. 
In vivo studies in rats were performed and their results showed no toxicity at 
up to 2000mg/kg/day in gavage dosing in the diet during of up 3 months. 
Other studies, where higher oral doses of chitosan were administered in a 
short-term human trials, reported chitosan as safe with no significant clinical 
symptoms and no evidence of an allergic response18.  
In vitro degradation of chitosan with human lysozyme occurs mainly through 
depolymerisation by enzyme. Chitosan membrane for periodontal guided 
tissue regeneration was tested, and the results showed that it had no toxicity, 
with no evidence of an inflammatory reaction18. 
Silva et Al evaluate the serum-starved human gingival fibroblast when 




measurement of LDH into the cell culture as medium as an indicator of cell 




Chitosan has been reported as highly biodegradable mainly due to the fact 
that under physiological condition its molecular chains can be degraded by 
enzymes such as lysozyme, chitinase, N-acetyl-D-glucosaminidase and 
lipases. The products of its degradation do not raise any critical concern 
because these products are oligosaccharides that are either incorporated into 
glycosaminoglycan and glycoprotein metabolic pathways or easily excreted in 
urine directly 6,26,28. Chitosan can be degraded by lysozyme through 
hydrolysis of acetylated residues and the degradation products are 
nontoxic28,29. 
On the one hand, many studies evaluated the degradation rate of chitosan 
preparations by different methods and conclude that degradation rate depend 
on their molecular weight and the preparation methods. For example, In vivo 
studies in rats showed that degradation occurred less rapidly as the degree of 
deacetylation become higher and we can conclude that the rate of 
degradation is inversely proportional to the degree of deacetylation 24,28. 
On the other hand, if there is a rapid degradation of chitosan, it may result in 
an accumulation of amino sugars, inducing an inflammatory response and, 
hence, affecting chitosan biocompatibility26. 
 
Wound Healing Effect  
Chitosan promotes granulation and organization which is beneficial for the 
wound healing6. It has been reported that chitosan plays an important role in 
the early phase of wound healing because it increases the infiltration of 
Polymorphonuclear cells (PMNs) which is followed by the collagen production 
of fibroblasts. The stimulation of fibroblasts ensures the production of 
interleukon-8 (IL-8) which plays an important role in chemotaxis and 
angiogenesis. It performs complement activation in an alternative manner 
because it increases the production of C5a which increases migration and 




the phases of the macrophage activation, cytokine production, giant cell 
migration and stimulation of type IV collagen synthesis30. Chitosan has  the 
capacity to foster adequate granulation tissue formation accompanied by 
angiogenesis and regular deposition of collagen fibres6. 
In vivo and in vitro studies have indicated that an enzymatic degradation of 
the chitosan oligomers in a wound environment will produce stimulatory 
effects on macrophages and the migratory activity is significantly enhanced4. 
Silva et Al concluded that chitosan is well tolerated by gingival fibroblasts and 
a synergistic response with some growth factors as Platelet-derived-growth 
factor (PDGF is one of the numerous growth factors that regulate cell growth 
and division and plays a significant role in angiogenesis) may stimulate cell 
proliferation in gingival fibroblasts3. 
 
Antimicrobial/antibacterial effect 
Chitosan has been investigated as an antimicrobial material against a wide 
range of target organisms, including, bacteria, yeasts and fungi20. 
A number of studies demonstrated a bacterial effectiveness of chitosan on 
Gram-negative and Gram-positive bacteria. Oral bacteria includes 
Streptococcus, Staphylococcus, Actinobacillus and various anaerobes in 
particular bacteroides18,20.  
A key character from other polysacharoses is that chitosan can form a 
polycationic structure that can bound the aninons on bacterial surface. The 
interaction between the anionic components of bacteria and the positive 
charge of chitosan could weaken the barrier function of the outer membrane 
of microorganisms18. 
Rejane C. Goy et al proposed three mechanisms of interaction between 
chitosan and microorganisms: a) the ionic surface interaction resulting in a 
wall cell leakage, b) the inhibition of the mRNA and protein synthesis via the 
penetration of chitosan into the nuclei of the microrganisms and c) the 
formation of an external barrier chelating metal and provoking the suppression 
of essential to microbial growth. These mechanisms can occur simultaneously 
but with different intensities20. 
The effect of chitosan on Actinobacillus actinomycetemcomitans and 




antimicrobial action at a very low concentration. Moreover, chitosan 
selectively inhibited streptococci mutans adsorption to hydroxyapatite. 
Chitosan can also penetrate into biofilms formed by the pathogenic fungus as 
Cryptococcus neoformans and damage fungal cells resulting in a reducing in 
the metabolic activity of the biofilms and cell viability18.  
 
Hemostatic effect 
A range of studies has shown that chitosan acts as a hemostatic agent which 
clot formation appears to be due to an interaction between the cell membrane 
of erythrocytes and chitosan, in absence of coagulation factors or platelets. 
The mechanism of this action has not been clearly well-known but it seems to 
be a mechanism which the reactive amino groups of chitosan interacts with 
blood cells. The positive charge of chitosan and negative charge of the 
membranes of erythrocytes and platelets are attracted leading to platelet 
activation and thrombus formation28,31,32. 
In vivo tests in heparinized rats showed a putative capacity to induce clot 
formation in the absence of coagulation factors which allows to support the 
idea that chitosan can be very useful in patients with coagulopathies or those 
who are therapeutically anticoagulated33. 
Celox, HemCon and Quikclot are chitosan-containing medical devices 
marketed in Europe and the US for the treatment of bleeding and have been 




The term bioadhesion correspond a bond or an adhesive interaction 
established between two biological surfaces or a biological and synthetic 
surface1. 
Chitosan hydrogels have a high adhesive force due to adequate water 
absorption capacity with the cationic nature that will promote binding to the 
negative surface of the mucosa. It allows to have another important propriety: 
the intrinsic bioadhesive propriety of chitosan hydrogel that maintain an 




swelling is the key to guarantee adhesion, however, over hydration can form 
slipper non-adhesive hydrogels10.  
The positive charge of chitosan has the special feature of adhering to mucosal 
surfaces. The variety of forms of chitosan in terms of molecular weight and 
degree of deacetylation affect the solubility and mucoadhesivity. If the 
deacetylation degree decreases, the solubilisation becomes more difficult and 
the mucoadhesive capacity of the polymer also decrease due less positively 
charged amino groups available for the interaction with negatively charged 
residues of the mucus. This means that highly deacetylated chitosan has 
more mucoadhesion which is responsible for a more prolonged retention in 
the site of action or absorption26. 
 
Bone engineering 
Scaffolds for bone tissue engineering must have a highly porous and 
interconnected pore structure because greater porosity and pore size usually 
means a higher surface area/volume ratio, thus favouring cell adhesion to the 
scaffold and promoting bone tissue regeneration34. 
Chitosan can also be a fundamental issue of concern in bone engineering 
because their adhesion represents a requisite for the matrix secretion by 
osteoblasts, which are anchorage dependent cells35. It exhibits an 
osteocondutive effect and potentiates the differentiation of osteoprogenitor 
cells that facilitate bone formation4. 
In periodontal study it was possible to verify that chitosan produced  a 
radiographic benefit to bone relative to the control treatment24. 
In vivo tests in rats showed that grafting chitosan membranes into rat 
subcutaneous tissue maintained their shape and space for bone regeneration 
for 6 weeks.  Their biodegradability and the degradation rate could be 
managed to fit into the schedule of remodelling of tissue regeneration18 
On the other hand, Xiaoning He et al refers that pure chitosan scaffold is 
fragile and lacks the bioactivity to induce hard tissue formation, which can 
limits it application in bone tissue engineering34.  
Chitosan membranes were tested and showed that they induced more 
amount of new cementum and bone, and that cementoblast and osteoblast 




 Pre and Postoperative management techinques 1.4.
Surgeons must remain careful to use methods to avoid complications during 
and after surgeries, recognizing and eliminating the most possible  risk 
factors, and these procedures must begin before any surgery. In third molar 
surgery risk factors that would increase the possibility of developing problems 
include: nerve damage, pain, swelling and infection36. 
In order to prevent nerve damage the main risk factors were found to be: the 
skills and the experience of the operator, the type of impaction and the 
proximity of the tooth to the nerve which may be radiographically provided36. 
One of the most important priorities for the dental patient visiting clinicians is 
that they have a pain-free experience which can be obtained with the aid of 
medication. The use of  local anaesthetics after the surgical intervention 
provide an environment which is more comfortable for the patients36. 
Corticosteroids are recognised for their ability to decrease discomfort with the 
reduce postoperative pain, trismus and facial oedema36. 
Paracetamol (acetaminophen) is consider safe in the treatment of 
postoperative pain relating third molar removal, having the benefit of reducing 
pain intensity at both 4 and 6 hours36. 
Ibuprofen has an superior effect in providing a pain relief comparing to the 
paracetamol but the combination of these two medications confirms a high-
quality evidence in analgesia and suggests an superior effect around 8 hours.  
The use of ice has yielded positive results with the benefits of reducing the 
discomfort experienced with postoperative swelling due the reduce of local 
temperature and cellular metabolism36.  
To help reduce the incidence of alveolar osteitis (dry socket), osteomyelitis 
and other unwanted complications, oral surgeons will often consider the use 
















Chitosan is a natural polymer that has shown a minimal body reaction and 
may be applied in periodontal therapy for tissue-reconstruction. The interest in 
the use of this polysaccharide as a pharmaceutical excipient is due to 
biocompatibility, biodegradable, antimicrobial, non-toxic and hemostatic 
proprieties28. 
This experimental study will examine the potential of chitosan in the wound 
healing of the oral mucosa after impacted or submucous third molar surgery. 
The information collected and the conclusions of this study will be relevant in 
dentistry in order to improve the healing of oral tissues, decreasing 
postoperative complications and increasing patient comfort. 
This study aims to assess the effect of chitosan on the healing process of oral 
mucosa by evaluating postoperative symptoms after third molar extractions in 
open technique and with the chance to realize a primary wound closure in 
Oral Surgery in the University Clinic of the University Portuguese Catholic – 
Viseu. 
In order to do so, the effects of chitosan in the healing process of the oral 
mucosa will be assessed by evaluating the signs of inflammation present after 
the surgeries, and the following hypothesis will be addressed: 
H1: Chitosan allows an improvement in the healing process of the oral 
mucosa; 
H2: Chitosan affects negatively the healing process of the oral mucosa; 
















3. MATERIALS AND METHODS 
 
 Location and type of study 3.1.
This is an experimental pilot study type split-mouth design in which the 
application of the hydrogel of chitosan in a socket after extraction was 
evaluated and the wound healing of the oral mucosa for an extraction of 
contralateral tooth where chitosan was not applied in the socket was 
compared. All surgeries were performed by the same surgeon. 
 
 Duration and study period 3.2.
The study was conducted between January 2015 and June 2015. 
 
 Population study 3.3.
This study included 8 patients without systemic diseases, submucous or 
impacted mandibular teeth with indication for extraction and which will be 
possible to perform a primary wound closure. 
 
 Inclusion and exclusion criteria 3.4.
3.4.1. Inclusion criteria 
Patients with Indications for extraction; 
Submucous or impacted mandibular teeth which will be possible to perform a 
primary wound closure; 
Patients whose contralateral tooth is indicated for extraction; 
Patients without systemic diseases;  
Informed consent before conducting a healthcare intervention and the study; 
3.4.2. Exclusion criteria  
Teeth with indication for extraction but where a primary wound closure will not 
be possible to be performed; 
Maxillary teeth indicated for extraction; 
Patients with systemic diseases; 




Figure 1: Preoperative redness. 
Patients who can’t attend controls. 
 
 Preparation of chitosan hydrogel 3.5.
The chitosan hydrogel was obtained by dissolving chitosan with a molecular 
weight 10-50 Da and 90% degree of deacetylation in 1% acetic acid with 1 N 
NaOH. This hydrogel has a concentration of 3% and pH 5,6. 
There was an especial care in dissolving chitosan because its granules did 
not have enough tissue biocompatibility and were determent to regular 
epithelization33. 
Our biomaterial was kept within the socket through primary wound closure. 
 
 Definition of the variables in study and strategy for the treatment of 3.6.
data 
The following variables were studied at different stages of all healing process: 
redness, swelling, pain, loss of function, bleeding.  
The data for each variables  were recorded at the following periods: 24h, 48h, 
72h, 1 week and 2 weeks. 
A semi-quantitative analysis of some cardinal signs of the inflammation 
(redness, swelling, pain and loss of function) and bleeding was made.  
Preoperative and postoperative redness and swelling were evaluated taking 
into account the initial colour of the oral mucosa (figure 1 and 2)  and the 
shape of the face / mandibular angle (figure 3), respectively. Loss of function 
was evaluated by the presence / absence of trismus.  
 
  




















A questionnaire was also given to evaluate the postoperative symptoms and 
medication. Pain was evaluated through a Visual Analogue Scale (VAS). 
Data was recorded in tables accordingly to each day of follow up by the 
presence or absence of each sign or symptom. 
Graphics were created for each variable in order to evaluate differences 
between chitosan and control, taking time variable into account. 
 Follow up and factors to consider 3.7.
In this study a split-mouth design of 8 patients was used. The follow up was 
conducted at all healing process and it was performed photographically to be 
subsequently analysed. Medication and postoperative cares performed by the 
patient were also taken into account.  
The medication used was the same for all patients: Amoxicillin + Clavulanic 
acid, Paracetamol and Ibuprofen. Deflazacort was prescribed only if 
osteotomy was performed. 
Removal of suture was performed 1 week after the surgery. 
Figure 3: Postoperative swelling visible in 





 Randomization of the study 3.8.
Although the population is aware of the study, surgeries were performed 
without the patients to know what the case control would be or the case with 
application of the hydrogel of chitosan in a socket after extraction. 
 Clinical Settings 3.9.
The surgical removal of third molars is one the most performed procedures in 
oral and maxillofacial surgery but the anatomic positions and angulations of 
these teeth commonly result in a high degree of dental impaction. 
Radiological individual anatomy, demographic aspects and operative factors 
are considered important variables to the determination of surgical difficulties 
and we adopted methods in our clinical practice in order to minimize the trans- 
and postoperative complication risks 37.  
A structured and standardized surgical planning was devised where a pre-
operative assessment of the patient’s condition with a clinical examination and 
radiological assessment were conducted. This allowed us to obtain additional 
information about the associated anatomical structures and evaluate the 
possible intraoperative complications that may occur. 
The benefits or indication of impacted tooth and third molar extraction include 
the relief and stop pain (that in some cases comes with unexplained origin), 
prevention of caries, periodontal disease, a single or multiple episodes of 
pericoronitis, facilitation of orthodontic treatment and orthognathic surgery and 
the prevention of pathological conditions such as dentigerous cyst formation 
and external root resorption of the adjacent teeth38. 
These surgical procedures can have some intraoperative and postoperative 
risks or complications. The most common complications are pain, swelling, 
and trismus. Besides, other risks that are described in the literature may occur 
as less frequent such as nerve damage leading to a temporary paraesthesia 
of the lips, tongue and chin, hemorrhage, alveolar osteitis (dry socket), soft 
tissue infection, fracture of the mandible or maxilla, damage to adjacent teeth 
sinus exposure or infection or anaesthetic complication.38,39 
This experimental study was conducted in the university clinic of the 
University Portuguese Catholic – Viseu and the surgeries were always 




 Surgical instructions after third molar surgery 3.10.
Third molar surgery is one of the most common surgical procedures 
performed in dental surgery and in order to minimize postoperative damage 
and improve quality of life of patients after surgery were given the following 
instructions: 
 Apply a baggie filled with ice to the side of face where surgery was 
performed during the 12-24 hours after surgery; 
 Performing a soft food diet on the day and day following surgery and 
avoid hard, crunchy foods after the third day till they can restore a 
normal diet. 
 No smoking in the 3 days following surgery (however none of our 
patients were smokers); 
 Do not consume alcoholic beverages in the 24 hours after surgery or 
while taking pain medications and antibiotic; 
 Avoid spitting the day of the surgery; 
 Do the cleaning near the surgical site smoothly; 
 Do not use a straw for 3 days following surgery; 
 Avoid strenuous exercise, jogging, or sporting activities that may cause 
an increase in blood pressure, in the next 48h after surgery; 
 Keep the head elevated at a 30 - 45 degree angle (lying flat will 
increase the blood flow to the head, and cause more bleeding and 
swelling); 
 Fill the prescription for a pain reliever and antibiotic at the pharmacy 
and take all medication as instructed: Anti-inflammatory (Ibuprofen, 
600mg) 3x per day; Pain killers (Paracetamol, 1000mg) in case of 
S.O.S; Antibiotic (Amoxicilin + clavulanic acid, Clavamox® 875/125mg) 
2x per day for 8 days; Corticosteroid (Deflazacort, 30mg) – 90-120mg 
in the first day and gradually reduce the dose to reach the minimum 
















In the following tables where the data of follow up was recorded, the symbol • 
signify presence and the - signify absence of the variable.  







Radiological exam: orthopantomography 
 
Figure 4: Patient 1 – Orthopantomography 
Chitosan (Q): tooth 4.8  
Pell and Gregory classification: I B 
Intervention Time: <30 minutes 
Suture: 3 simple points 
Control (C): tooth 3.8 
Pell and Gregory classification: I B 
Intervention Time: <30 minutes 
Suture: 3 simple points 
 
Table 1: Patient 1 - Postoperative evaluation 
       


















Pain - • - • - - - - - - 
Redness • • - • - • - - - - 
Swelling - • - • - • - - - - 
Loss of function - • - • - • - - - - 
Bleeding - • - • - - - - - - 






Radiological exam: orthopantomography 
 
Figure 5: Patient 2 – Orthopantomography 
Chitosan (Q): tooth 3.8  
Pell and Gregory classification: II B 
Intervention time: <30 minutes; 
Suture: 3 simple points. 
Control (C): Tooth 4.8 - It was performed osteotomy. 
Pell and Gregory classification: II B 
Intervention time: <30 minutes; 
Suture: 3 simple points. 
 
Table 2: Patient 2 - Postoperative evaluation 
 
       


















Pain - - - - - - - - - - 
Redness • • • • • • - • - • 
Swelling • • - • - • - - - - 
Loss of function • • - • - - - - - - 
Bleeding - • - • - • - - - - 





Radiological exam: orthopantomography 
 
Figure 6: Patient 3 – Orthopantomography 
Chitosan (Q): tooth 4.8 - It was performed osteotomy. 
Pell and Gregory classification: I B 
 Intervention time: <30 minutes; 
Suture: 3 simple points. 
Control (C): Tooth 3.8 
 Pell and Gregory classification: II B 
Intervention Time: <30 minutes; 
Suture: 3 simple points 
 
Table 3: Patient 3 - Postoperative evaluation 
       


















Pain - - - - - - - - - - 
Redness • • - • - • - • - - 
Swelling - - - -  - - - - - 
Loss of function - - - - - - - - - - 
Bleeding - • - • - - - - - - 






Radiological exam: orthopantomography 
 
Figure 7: Patient 4 – Orthopantomography 
Chitosan (Q): tooth 4.8 
Pell and Gregory classification: I B; 
Intervention Time: <30 minutes; 
Suture: 4 simple points. 
Control (C): Tooth 3.8 
Pell and Gregory classification: I B; 
Intervention Time: <30 minutes; 
Suture: 3 simple points. 
 
Table 4: Patient 4 - Postoperative evaluation 
       


















Pain - • - • - • - - - - 
Redness • • • • • • - • - • 
Swelling • • - •  •  •   
Loss of function - • - • - • - • - - 
Bleeding - • - - - - - - - - 






Radiological exam: orthopantomography 
 
Figure 8: Patient 5 – Orthopantomography 
Chitosan (Q): tooth 3.8 - It was performed osteotomy 
Pell and Gregory classification: II B; 
Intervention Time: 30 - 60 minutes. 
Suture: 3 simple points. 
Control (C): tooth 4.8 
Pell and Gregory classification: I B; 
Intervention Time: <30 minutes. 
Suture: 3 simple points. 
 
Table 5: Patient 5 - Postoperative evaluation 
       


















Pain • - - - - - - - - - 
Redness • • • • - • - - - - 
Swelling • • • • •      
Loss of function • • • - • - - - - - 
Bleeding - • - - - - - - - - 






Radiological exam: orthopantomography 
 
Figure 9: Patient 6 – Orthopantomography 
Chitosan (Q): tooth 3.8 
 Pell and Gregory classification: I B 
 Intervention Time: <30 minutes; 
 Suture: 3 simple points. 
Control (C): tooth 4.8 - It was performed osteotomy; 
 Pell and Gregory classification: II B 
 Intervention Time: 30 - 60 minutes; 
 Suture: 3 simple points. 
 
Table 6: Patient 6 - Postoperative evaluation 
       


















Pain - • - • - - - - - - 
Redness • • - • - • - - - - 
Swelling • • • • - - - -   
Loss of function - •  •  •  •  - 
Bleeding - - - - - - - - - - 







Radiological exam: orthopantomography 
 
Figure 10: Patient 7 – Orthopantomography 
Chitosan (Q): 4.8 
Pell and Gregory classification: II B 
Intervention Time:  <30 minutes; 
Suture: 3 simple points. 
Control (C): 3.8 
Pell and Gregory classification; I B; 
Intervention Time: <30 minutes; 
Suture: 3 simple points. 
 
Table 7: Patient 7 - Postoperative evaluation 
       


















Pain - - - - - - - - - - 
Redness • • • • - • - •   
Swelling - - - - - - - - - - 
Loss of function - - - - - - - - - - 
Bleeding - • - • - - - - - - 






Radiological exam: orthopantomography 
 
Figure 11: Patient 8 – Orthopantomography 
Chitosan (Q): tooth 4.8 
Pell and Gregory classification: II B; 
Intervention Time: <30 minutes; 
Suture: 3 simple points. 
Control (C): tooth 3.8 
Pell and Gregory classification: I B; 
Intervention Time: <30 minutes; 
Suture: 3 simple points. 
 
Table 8: Patient 8 - Postoperative evaluation 



















Pain - • - - - - - - - - 
Redness • • • • • • - • - - 
Swelling - • - • - - -  -  
Loss of function • • - • - • - - - - 
Bleeding - • - • - • - • - - 




Table 9: All results of the postoperative evaluation 






1 2 3 4 5 6 7 8 




24h - • - - - - - • • - - • - - - • 
48h - • - - - - - • - - - • - - - - 
72h - - - - - - - • - - - - - - - - 
1 week - - - - - - - - - - - - - - - - 




24h • • • • • • • • • • • • • • • • 
48h - • • • - • • • • • - • • • • • 
72h - • • • - • • • - • - • - • • • 
1 week - - - • - • - • - - - - - • - • 




24h - • • • - - • • • • • • - - - • 
48h - • - • - - - • • • • • - - - • 
72h - • - • - - - • • - - - - - - - 
1 week - - - - - - - • - - - - - - - - 





24h - • • • - - - • • • - • - - • • 
48h - • - • - - - • • - - • - - - • 
72h - • - - - - - • • - - • - - - • 
1 week - - - - - - - • - - - • - - - - 




24h - • - • - • - • - • - - - • - • 
48h - • - • - • - - - - - - - • - • 
72h - - - • - - - - - - - - - - - • 
1 week - - - - - - - - - - - - - - - • 





 A case example of follow up 4.1.
 
Follow up: 24h 
 










                                                 
Follow up: 48h 











Figure 13: Control, day 1 
Figure 15: Control, day 2 Figure 14: Chitosan, day 2 




Follow up: 72h 
Chitosan     Control 
 
Follow up: 1 week 






















Figure 16: Chitosan, day 3 Figure 17: Control, day 3 
Figure 19: Control,1 week Figure 18: Chitosan, 1 week 




Follow up: 2 weeks 




Figure 25: Control, 2 weeks Figure 24: Chitosan, 2 weeks 



















































































































































































5.  DISCUSSION 
 
The ideal biomaterial for wound healing needs to be biocompatible, ensure 
that the wound remains moist with exudates, but  not macerated, free of 
infection, guarantee uniform cell distribution, maintain cell viability and 
phenotype and should induce migration and proliferation of epithelial cells, 
fibroblasts and endothelial cells as well as the synthesis of extracellular matrix 
components for wound repair9.  
Chitosan is a linear copolymer derived from crustacean’s exoskeletons such 
as shrimp and crab that has been largely investigated due to its favourable 
proprieties in medical areas. The positive charge of chitosan is soluble in a 
low pH environment and it has an important capacity to promote the wound 
healing process due to their biocompatible, biodegradable, hemostatic and 
antibacterial abilities. All these factors make chitosan hydrogel a highly 
desirable product4,8,40.  
In this pilot study, a total of 8 patients received surgical extraction of impacted 
or submucous third molar by the same surgeon with the aim of evaluating the 
effects of chitosan in the healing process of the oral mucosa as compared 
with a contralateral tooth extraction which didn’t use chitosan. 
When the data of redness (Table 11) was analysed we found out that 24 
hours after each surgery all patients had redness in the surgical area. The 
differences begin to emerge in the next days of follow up. In the cases control 
all patients showed redness at 48h and 72h. One week after surgeries the 
percentage of patients with redness decreased to 62.5% and in the second 
week to 25%. In surgeries where chitosan was used it was observed a 
progressive decrease in the percentage of patients with redness: after 48h 
and 72h the percentage was 62.5% and 37.5%, respectively. One week later 
there wasn’t redness in the surgical area. After 2 weeks of follow up the visual 
result of healing of the oral tissues was similar in both cases. 
This can be explained by the ability of chitosan to play an important role in the 
early phase of wound healing and increase angiogenesis. Chitosan attracts 
and activates neutrophils and macrophages and enhances the expression of 
cytokines and growth factors4,6. It also facilitates the wound healing by 




To what regards the swelling, pain and loss of function (table 10, 12, 13), we 
also verified a slight decrease in cases where the chitosan was used. It 
should be noted that in most cases where swelling and loss of function have 
occured, both corresponded to the cases in which osteotomy has been 
performed, even if performed in a minimally invasive way. The increase of 
surgical intervention time was found to lead to increase pain, swelling and 
trismus (which correspond to loss of function) following lower third molar 
surgery14.  
A possible initial slightly raised pain scores in sites with chitosan could be 
explained by the presence of acid acetic until it is fully dissolved in oral 
fluids31. 
The hydrophilic surface of chitosan promotes cell adhesion and proliferation34. 
Platelets adhere and aggregate on chitosan which promote hemostasis. This 
supports the previous finding that chitosan reduces the inflammatory 
response, improving the inflammation stage and consequently proliferation 
will increase and enhanced collagen deposition will occur during remodelling 
which accelerate wound healing41. Chitosan improves the tensile strength of 
wound by speeding up the fibroblastic synthesis of collagen in the first few 
days of wound healing42. Because of its bioadhesive properties, it’s expected 
that chitosan remains for prolonged time on the application site25. 
In vitro assays showed that chitosan can stimulate the proliferation of human 
periodontal ligament cells and recruit vascular tissue growth which provide 
considerable evidence that chitosan helps the regeneration of periodontal 
cells18. Silva et al assessed whether chitosan is able to stimulate cell 
proliferation and if it collaborates with other growth factors such as PDGF to 
exert is mitogenic effect. They observed that chitosan stimulates cell viability 
and promotes cell proliferation in human gingival fibroblasts3. Moreover, 
periodontal ligament in the presence of chitosan presented more regular 
pattern and a denser fibre arrangement than those in the surgical control 
group18. 
Histological observations in wound healing experiments using a mouse model 
showed that wounds treated with chitosan hydrogel have an advanced 




application of chitosan hydrogel onto an open wound induces significant 
wound contraction and accelerates the wound closure and healing43. 
The role of chitosan in wound healing was supported by studies that had 
shown that chitosan amino groups are recognised by the immune system 
which induce migration of inflammatory cells and fibroblasts to the wound 
area, being activated to produce multiple cytokines. Fibroblasts are stimulated 
by chitosan molecules to secrete IL-8 and other cytokines, which in turn could 
induce angiogenesis, fibrosis and epithelialization28,43. 
Duygu B. et al evaluate the effect of chitosan gel comparing with its 
combination with collagen membrane and with flap alone on periodontal 
regeneration applied into the intraosseous lesions. They conclude that all 
treatment modalities provide improvements in clinical measurements of tissue 
regeneration. They also observed no inflammatory reaction following the 
application of chitosan in gel form25.  
The antimicrobial activity of chitosan also promotes the repair of damaged 
tissue preventing infection of the wound6,41,42. Chitosan increases permeability 
of the inner and outer membranes and ultimately disrupt the bacterial cell 
membranes, releasing their contents. Chitosan provides an antibacterial 
barrier against a wide range of Gram-positive and Gram-negative organisms, 
including such as methicillin-resistant Staphylococcus, mancomycin-resistant 
enterococcus and Acinetobacter baumannii31. 
Chitosan also has the ability to impair the colonization of the tooth surface by 
Streptococcus mutans which prevents a possible infection after surgery25. 
Chun Xu et al studied chitosan membranes in animal models and they 
conclude that they are cheaper and due to their property of bacteriostatisis it 
may reduce the bacteria contamination and benefit periodontal tissue 
regeneration18.  
Chitosan was also used in veterinary medicine because of its ability to 
accelerate the healing process and due to their antibacterial property. In vivo 
and in vitro studies have indicated that enzymatic degradation of chitosan 
oligomers origin a wound environment that produces a stimulatory effect on 
macrophages35. 
The hemostatic activity is an important phase in the early treatment of an 




(87.5%) bled on the following day after surgery, 5 patients (62.5%) continued 
to bleed past 48 hours, 2 patients (25%) bled at 72h and only 1 patient 
(12.5%) was still bleeding one week after surgery. This didn’t happen in cases 
where the chitosan was used. None of these patients had bleeding in the days 
following surgery, allowing us to report a peculiar ability of chitosan in 
hemostasis.  
This happened due to the interaction of chitosan with blood cells. The outer 
membranes of erythrocytes and platelets are negatively charged and get 
attracted to the positively charged reactive amino groups of chitosan leading 
to platelet activation and thrombus formation28,32. 
This agrees with Y.Okamoto et al that conclude that chitin and chitosan 
enhance blood coagulation, and this phenomenon was more effective in 
chitosan than chitin. In their experimental studies they conclude that chitosan 
reduces blood coagulation time not only due to a physical effect of chitosan, 
but also related to their chemical structure, particularly amino groups that was 
important in platelets aggregation44. Electrophoretic and Western blot analysis 
of red blood cell surface proteins demonstrated that chitosan microfibers were 
bound to band three of the red blood cells and this interaction leads to the 
activation of the intrinsic coagulation cascade45. 
Intravenous dosing (50mg/kg/day) of chitosan in rabbits showed some deaths 
(but no effects at 4.5mg/km/day) and oral dosing at up to 800mg/kg/day in this 
species exhibited to be well tolerated which is probably due to blood cell 
aggregation28. 
A common approach to managing patients with oral anticoagulant therapy is 
to suspend the medication for 3 to 4 days before surgery, which exposes the 
patients to a higher risk of thromboembolism, myocardial infarction, and 
cardiovascular accidents. The use of chitosan minimises this risk by allowing 
the patient to continue his antiplatelet medication, but he still needs the 
postoperative evaluation and management of a patient’s INR status31. 
HemCon® is a FDA approved chitosan dressing, that was manufactured from 
chitosan and molds to form a highly electropositive sponge-like material that 
bids to negatively charged red blood cells and in result rapidly form a viscous 
clot that seals the wound site and facilitate hemostasis. The use of this 




therapy) was evaluated and hemostasis was achieved in less than 1 minute 
and the control wounds in 9.54 minutes21,46. 
Tejraj P. Kale et al evaluate the effectiveness of the same product in 
controlling post-extraction bleeding compared to conventional methods in 
patients receiving oral antiplatelet therapy. The time to hemostasis was 
shorter in the case of chitosan product than using the conventional methods. 
The self-adhesive nature of HemCon® is caused by electrostatic attraction of 
red blood cells to the chitosan which it forms a dense viscous mass that 
provides adhesion and it seals the wound site. It allows the body form a clot 
naturally and activate its coagulation pathway effectively, initially forming 
organised platelets31. Moreover, it was found an improvement in the 
postoperative healing with minimal complications comparing the control site. It 
may be attributed a release of growth factor from human platelets stimulated 
by chitosan exposure and the antibacterial proprieties of chitosan. The 
investigation involved the application of a HemCon® in a full-thickness 
excisional wound in mice that had been infected with pathogenic bacteria 
such as Pseudomonas aeruginosa, Proteus mirabilis, and Staphylococcus 
aureus showed that chitosan not only kill the bacteria but also stimulate 
wound healing47. 
Sertac A. et al evaluate the effects other product made from chitosan in 
warfarin-treated rats and a great success in controlling bleeding 
intraoperatively and postoperatively was observed. It interacts directly with red 
blood cells and platelets to form a cross-linked barrier clot, independent of 
native factors. It also increases the tissue factor activity, the major initiator of 
the extrinsic coagulation cascade which is involved in all phases of the host 
response to wounding, implying a likely central role for the tissue factor in 
wound healing. It was also observed an insufficient resorption of chitosan 
granules and they recommend to remove them carefully and totally from the 
wound to avoid epithelization troubles and gain success in early-stage wound 
healing33. 
Other studies involving other abilities of chitosan such as osteogenic activity 
showed a tissue and cell formation during wound healing and augments new 




more amount of new cementum and bone with a densely arranged 
cementoblasts and osteoblasts along the new bone surface18. 
Another important aspect is the postoperative care that patients had. Not all 
have the same care as, for example, to make the medication after surgery, 
put the ice packs in a controlled manner and for several periods of time. All 

















Patients satisfaction is a key to compliance and the business success of the 
dental clinic38. In this pilot study, through an split mouth design, we evaluate 
the influence of chitosan in the healing process of the oral mucosa.  
After analysing of the results, it may be concluded that the chitosan influences 
the healing process. Some classic signs of inflammation were observed in a 
short period of time where chitosan acts compared to the control. Literature 
reports that chitosan favours the early phase of healing process by attraction 
and activation of neutrophils and macrophages, cytokine production using 
macrophages and fibroblasts and angiogenesis stimulation4. It also favours 
the granulation tissue formation and the epithelialization43.  
Hemostatic effect and antimicrobial activity also play an important role in 
wound healing. Bioadhesive ability of chitosan hydrogel allows that it 
maintains an intimate contact with oral mucosa10. This propriety together with 
the primary intention wound closure performed by surgeon its permit that 
chitosan remains for prolonged time on the application site. 
The hemostatic ability of chitosan was observed in our study. According to the 
literature the chitosan can be used in patients who are take oral anticoagulant 
medication allowing the patient continues the medication prior to surgery31. 
The studies also conclude that chitosan allow a regular deposition of collagen 
fibres leading more regular pattern and a denser fibre arrangement 6,18.  
These unique biologic proprieties and the inexpensive cost of chitosan are 
important for the practice in dentistry because it eliminates any additional 
material necessity, such as barrier membranes and grafts in regenerative 
dentistry, which will enable the surgeon to spend less time in operation and 
offer more economical treatment option for the patient 25,29. 
In a further analysis it would be important to analyse the data more 
specifically using for example biomarkers of inflammation. 
Future studies should be conducted, taking into account not only the influence 
of chitosan in the soft tissues but also in the regeneration of hard tissues. 
Other studies should be conducted by associating chitosan with other drugs in 





After this study it was concluded that chitosan could be essential in a 
postoperative quality of patients, allowing a rapid healing of the wound, with 
less complications. 
 Limitations of study 6.1.
In this study a semi-quantitative evaluation of the variable in study was 
realized. 
Although patients were blinded the surgeon and the analyser knew what the 
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PARA PARTICIPAÇÃO EM INVESTIGAÇÃO 
de acordo com a Declaração de Helsínquia  e a Convenção de Oviedo 
 
Por favor, leia com atenção a seguinte informação. Se achar que algo está incorreto ou que não está 
claro, não hesite em solicitar mais informações. Se concorda com a proposta que lhe foi feita, queira 
assinar este documento. 
 
Título do estudo: The effects of chitosan in the healing process of the 
oral mucosa 
 
Enquadramento: Investigação de âmbito académico a efetuar na Clínica 
Universitária da Universidade Católica Portuguesa, tendo como responsável 
o Professor Doutor Rui Amaral Mendes, docente da Universidade Católica 
Portuguesa, e o aluno do 5ºAno do Mestrado Integrado em Medicina 
Dentária, Gonçalo João Pereira de Jesus. 
 
Explicação do estudo: O estudo a realizar é um split-mouth design que 
envolve a aplicação de um gel de quitosano no alvéolo após a extração de 
um dente incluso/submucoso no qual será posteriormente comparado o seu 
processo de cicatrização relativamente à extração do dente contralateral, 
onde não será aplicado o gel anteriormente mencionado. O controlo será 
realizado fotograficamente e através do exame intra-oral nas 24h, 48h, 72h, 1 
semana e 2 semanas após o procedimento cirúrgico. Será também utilizada a 
Escala Visual Analógica para avaliação e monitorização da dor. 
 
Condições: Este estudo não envolve procedimentos que não se enquadrem 





A participação neste estudo é totalmente voluntária, não acarretando 
quaisquer custos, podendo retirar o seu consentimento em qualquer etapa do 
estudo, sem necessidade de facultar explicações aos seus responsáveis e 
com total  a ausência de prejuízos, assistenciais ou outros, caso não queira 
participar. 
Ao decidir participar pode efetuar todas as questões que considerar 
necessárias para o seu esclarecimento ou facultar informações aos 
responsáveis do estudo em qualquer etapa do mesmo. 
  
Confidencialidade e anonimato: Os dados recolhidos para o presente 
estudo são de uso exclusivo do investigador e tratados de modo a garantir a 
sua confidencialidade. A informação recolhida será tratada com a máxima 
confidencialidade promovendo o seu anonimato. A análise dos dados 
recolhidos será efectuada em ambiente que garanta a privacidade dos 
mesmos, sendo os mesmos utilizados exclusivamente pelos investigadores 
envolvidos no projecto. 
 
Assinatura/s dos responsáveis pelo projecto: 
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verbais que me foram fornecidas pela/s pessoa/s que acima assina/m. Foi-
me garantida a possibilidade de, em qualquer altura, recusar participar neste 
estudo sem qualquer tipo de consequências. Desta forma, aceito participar 
neste estudo e permito a utilização dos dados que de forma voluntária 
forneço, confiando em que apenas serão utilizados para esta investigação e 
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Analog Visual Scale: Scale used to assess pain in patients49.
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